# MTX-related Liver Toxicity in Psoriasis Patients, Using Ultrasound-based Techniques as a Diagnostic Tool

> **NCT04168619** · — · UNKNOWN · sponsor: **The University of Hong Kong** · enrollment: 50 (estimated)

## Conditions studied

- Psoriasis
- Liver Fibrosis

## Interventions

- **DRUG:** Discontinue methotrexate
- **OTHER:** Medication depends on clinical judgement

## Key facts

- **NCT ID:** NCT04168619
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-10
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-07-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2020-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04168619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04168619, "MTX-related Liver Toxicity in Psoriasis Patients, Using Ultrasound-based Techniques as a Diagnostic Tool". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04168619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*